These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 16391877
1. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Hsu LS, Lee HC, Chau GY, Yin PH, Chi CW, Lui WY. Oncol Rep; 2006 Feb; 15(2):507-11. PubMed ID: 16391877 [Abstract] [Full Text] [Related]
2. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z. Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [Abstract] [Full Text] [Related]
3. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM. Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038 [Abstract] [Full Text] [Related]
4. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma. Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS. Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608 [Abstract] [Full Text] [Related]
5. Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma. Fukai K, Yokosuka O, Imazeki F, Tada M, Mikata R, Miyazaki M, Ochiai T, Saisho H. Liver Int; 2005 Dec; 25(6):1209-16. PubMed ID: 16343074 [Abstract] [Full Text] [Related]
6. Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis. Zhu YZ, Zhu R, Shi LG, Mao Y, Zheng GJ, Chen Q, Zhu HG. Exp Mol Pathol; 2010 Dec; 89(3):268-75. PubMed ID: 20620135 [Abstract] [Full Text] [Related]
7. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Schagdarsurengin U, Wilkens L, Steinemann D, Flemming P, Kreipe HH, Pfeifer GP, Schlegelberger B, Dammann R. Oncogene; 2003 Mar 27; 22(12):1866-71. PubMed ID: 12660822 [Abstract] [Full Text] [Related]
8. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G. Gastroenterology; 2008 Dec 27; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366 [Abstract] [Full Text] [Related]
11. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y. Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857 [Abstract] [Full Text] [Related]
12. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Oh BK, Kim H, Park HJ, Shim YH, Choi J, Park C, Park YN. Int J Mol Med; 2007 Jul 15; 20(1):65-73. PubMed ID: 17549390 [Abstract] [Full Text] [Related]
13. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis. Zhu R, Li BZ, Li H, Ling YQ, Hu XQ, Zhai WR, Zhu HG. Pathol Int; 2007 Jun 15; 57(6):328-36. PubMed ID: 17539963 [Abstract] [Full Text] [Related]
14. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma. Zhang C, Li Z, Cheng Y, Jia F, Li R, Wu M, Li K, Wei L. Clin Cancer Res; 2007 Feb 01; 13(3):944-52. PubMed ID: 17289889 [Abstract] [Full Text] [Related]
15. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma. Yeo W, Wong N, Wong WL, Lai PB, Zhong S, Johnson PJ. Liver Int; 2005 Apr 01; 25(2):266-72. PubMed ID: 15780049 [Abstract] [Full Text] [Related]
16. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Li X, Hui AM, Sun L, Hasegawa K, Torzilli G, Minagawa M, Takayama T, Makuuchi M. Clin Cancer Res; 2004 Nov 15; 10(22):7484-9. PubMed ID: 15569978 [Abstract] [Full Text] [Related]
17. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma. Zhang C, Guo X, Zhang L, Lu Z, Ma N, Cheng Y, Shen F, Zhang B, Wu M, Wei L. J Surg Oncol; 2008 Nov 01; 98(6):462-8. PubMed ID: 18683194 [Abstract] [Full Text] [Related]
18. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma. Park HJ, Yu E, Shim YH. Cancer Lett; 2006 Feb 28; 233(2):271-8. PubMed ID: 15885882 [Abstract] [Full Text] [Related]
19. Molecular and immunohistochemical study of the inactivation of the p16 gene in primary hepatocellular carcinoma. Huang J, Shen W, Li B, Luo Y, Liao S, Zhang W, Cheng N. Chin Med J (Engl); 2000 Oct 28; 113(10):889-93. PubMed ID: 11775834 [Abstract] [Full Text] [Related]
20. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI. Gastroenterology; 2007 Apr 28; 132(4):1476-94. PubMed ID: 17408664 [Abstract] [Full Text] [Related] Page: [Next] [New Search]